Overview
News
Salaries
Products
People
Growth
Offices
Financials

Funding and backers

Backers
1
Xontogeny
Momentum
0/100
no fresh signals
Last sign of life
this month
a posting or a news item
Tractionpublic signals, read monthly
Web presence
top 7%
of 133.2M domains by links, Common Crawl
Backed byfrom the funds' portfolios and accelerator catalogs
Similar startupsby what they do, their industry and backers
Biotia is advancing infectious disease diagnostics for patients managing challenging infections. Learn more about our work.
Apogee TherapeuticsFounded 2022 • 11-50 employees
ApogeeTherapeutics. Apogee is seeking to reshape the current standard of care for inflammatory and immune diseases because we believe…
Merida BiosciencesFounded 2021
Precision therapy for autoimmune-driven diseases is now within reach. Current treatments for autoimmune diseases are non-specific, often…
Locus BiosciencesVenture round $23.9M · 2 yr ago • Founded 2015 • 51-200 employees • 2 roles
Intelligent Automation-Powered Precision Medicines Engineering bacteriophage therapies for infectious diseases and immunology See How…
Diadem DX51-200 employees
"There is still no cheap and effective way to diagnose the disease...". – Voices of Alzheimer’s disease – Alzheimer’s association, 2008.
TareBio develops vaccines for cancer and infectious diseases by decoding immune responses to engineer targeted antigens.

Overview

Delve Bio leverages mNGS to empower labs and clinicians with the results they need to diagnose routine and rare infectious diseases.

News

News The New Yorker 1 month ago
Stumped by a Medical Mystery? Try Metagenomics
Jason Liebowitz on metagenomics, a new and powerful type of genetic testing that can search for thousands of different microorganisms in a single sweep to vastly speed up the diagnosing of uncommon infections.
Read more
Report
News genomeweb.com 8 months ago
Delve Bio Continues to Bolster Data on Metagenomic Sequencing Utility for Diagnosing CNS Infections
A newly published study modeling the impact of clinical metagenomic NGS testing suggests earlier diagnosis and significant cost savings for patients and providers.
Read more
Report
Pro access
Upgrade to see all 28 mentions
Upgrade to a paid plan to read every media mention of this company - funding news, awards, product launches and press releases from all the outlets writing about it.
Every media mention and press release
Funding news, awards and product launches
Fresh coverage from every outlet writing about the company
Upgrade now
Cancel anytime. Secure checkout. Instant activation.